Mitogen-activated protein kinase (MAPK)
- 1 December 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 33 (Suppl), S417-S419
- https://doi.org/10.1097/01.ccm.0000191714.39495.a6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- New insight into the pathogenesis of sepsis and the sepsis syndromeSurgery, 2005
- CALCIUM/CALMODULIN-DEPENDENT KINASE II IS REQUIRED FOR PLATELET-ACTIVATING FACTOR PRIMINGShock, 2005
- Dysregulation of the Immune Response in Severe SepsisThe Lancet Healthy Longevity, 2004
- c-Jun NH2-Terminal Kinase Inhibitor Anthra(1,9-cd)pyrazol-6(2H)-one Reduces Inducible Nitric-Oxide Synthase Expression by Destabilizing mRNA in Activated MacrophagesMolecular Pharmacology, 2003
- MAP KinasesChemical Reviews, 2001
- The p38 Mitogen-activated Kinase Pathway Regulates the Human Interleukin-10 Promoter via the Activation of Sp1 Transcription Factor in Lipopolysaccharide-stimulated Human MacrophagesJournal of Biological Chemistry, 2001
- Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactionsBiochemical Journal, 2000
- Inhibition of p38 MAP Kinase Activity Up-Regulates Multiple MAP Kinase Pathways and Potentiates 1,25-Dihydroxyvitamin D3-Induced Differentiation of Human Leukemia HL60 CellsExperimental Cell Research, 2000
- Mitogen-activated protein kinase pathwaysCurrent Opinion in Cell Biology, 1997
- Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and ThreonineJournal of Biological Chemistry, 1995